Literature DB >> 1353741

Sulphasalazine induced renal failure.

A D Dwarakanath1, J Michael, R N Allan.   

Abstract

Two men with longstanding ulcerative colitis who were treated with sulphasalazine for several years and who developed chronic renal failure are reported. Renal biopsy specimens showed histological changes consistent with drug induced chronic intestinal nephritis. Extensive investigation made other causes of chronic renal failure unlikely. One of these patients underwent renal transplantation, the other has impaired but stable renal function.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1353741      PMCID： PMC1379424          DOI： 10.1136/gut.33.7.1006

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  10 in total

1.  Acute interstitial nephritis due to 5-aminosalicylic acid.

Authors:  R P Mehta
Journal:  CMAJ       Date:  1990-11-15       Impact factor: 8.262

2.  [Acute interstitial nephritis caused by 5-aminosalicylic acid?].

Authors:  W Ruf-Ballauf; F Hofstädter; K Krentz
Journal:  Internist (Berl)       Date:  1989-04       Impact factor: 0.743

3.  Nephrotic syndrome associated with sulphasalazine.

Authors:  V M Barbour; P F Williams
Journal:  BMJ       Date:  1990-10-06

4.  [Chronic interstitial nephritis after treatment with 5-aminosalicylic acid].

Authors:  H V Henning; J Meinhold; T Eisenhauer; F Scheler; H J Gröne
Journal:  Dtsch Med Wochenschr       Date:  1989-07-07       Impact factor: 0.628

5.  Nephrotic syndrome after treatment with 5-aminosalicylic acid.

Authors:  B H Novis; Z Korzets; P Chen; J Bernheim
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-21

6.  [Nephritis from 5-aminosalicylic acid].

Authors:  K E von Mühlendahl
Journal:  Dtsch Med Wochenschr       Date:  1989-02-10       Impact factor: 0.628

7.  Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.

Authors:  K M Das; M A Eastwood; J P McManus; W Sircus
Journal:  N Engl J Med       Date:  1973-09-06       Impact factor: 91.245

8.  Acetylation of 5-aminosalicylic acid by isolated human colonic epithelial cells.

Authors:  A Ireland; J D Priddle; D P Jewell
Journal:  Clin Sci (Lond)       Date:  1990-01       Impact factor: 6.124

9.  Capacity-limited gut wall metabolism of 5-aminosalicylic acid, a therapeutically active metabolite of sulfasalazine, in rats.

Authors:  H J Pieniaszek; T R Bates
Journal:  J Pharm Sci       Date:  1979-10       Impact factor: 3.534

10.  Comparative nephrotoxicity of aspirin and phenacetin derivatives.

Authors:  I C Calder; C C Funder; C R Green; K N Ham; J D Tange
Journal:  Br Med J       Date:  1971-11-27
  10 in total
  10 in total

1.  Drug management of ulcerative colitis.

Authors:  S Barrow; S H Rees
Journal:  BMJ       Date:  1992-10-03

2.  Development of animal models underlining mechanistic connections between prostate inflammation and cancer.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  World J Clin Oncol       Date:  2013-02-10

3.  New salicylates as maintenance treatment in ulcerative colitis.

Authors:  G Järnerot
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

4.  Inflammatory Bowel Diseases Are Associated With an Increased Risk for Chronic Kidney Disease, Which Decreases With Age.

Authors:  Ravy K Vajravelu; Lawrence Copelovitch; Mark T Osterman; Frank I Scott; Ronac Mamtani; James D Lewis; Michelle R Denburg
Journal:  Clin Gastroenterol Hepatol       Date:  2019-11-01       Impact factor: 11.382

Review 5.  Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?

Authors:  A A van Bodegraven; Chris J J Mulder
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

6.  Are renal microgranulomas related to inflammatory tubular destruction?

Authors:  A Mahmood; D N Poller; J K Ramage
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

7.  Ulcerative colitis complicated by renal cell carcinoma: a series of three patients.

Authors:  J Satsangi; J Marshall; D Roskell; D Jewell
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

8.  No dose-dependent tubulotoxicity of 5-aminosalicylic acid: a prospective study in patients with inflammatory bowel diseases.

Authors:  Carsten Dehmer; Roland Greinwald; Juergen Löffler; Wolfgang Grotz; Lothar Wolf; Hans-Burkhardt Hagmann; Werner Schneider; Wolfgang Kreisel
Journal:  Int J Colorectal Dis       Date:  2003-02-08       Impact factor: 2.571

9.  Sulfasalazine-induced renal and hepatic injury in rats and the protective role of taurine.

Authors:  Reza Heidari; Maryam Rasti; Babak Shirazi Yeganeh; Hossein Niknahad; Arastoo Saeedi; Asma Najibi
Journal:  Bioimpacts       Date:  2016-03-28

10.  Sulfasalazine induces mitochondrial dysfunction and renal injury.

Authors:  Hossein Niknahad; Reza Heidari; Roya Mohammadzadeh; Mohammad Mehdi Ommati; Forouzan Khodaei; Negar Azarpira; Narges Abdoli; Mahdi Zarei; Behnam Asadi; Maryam Rasti; Babak Shirazi Yeganeh; Vahid Taheri; Arastoo Saeedi; Asma Najibi
Journal:  Ren Fail       Date:  2017-11       Impact factor: 2.606
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.